Similar articles

• [Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. I. Clinical evaluation].

  Michalska Z, Dubicka M, Nedoszytko B, Gajda A. Michalska Z, et al. Wiad Lek. 1987 Oct 15;40(20):1369-74. Wiad Lek. 1987. PMID: 2451357 Clinical Trial. Polish. No abstract available.
• [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].

  Dabrowska-Bernstein B, Stasiak A, Dabrowski M, Pawińska A, Cianciara J, Loch T, Babiuch L. Dabrowska-Bernstein B, et al. Pol Tyg Lek. 1990 Apr 16-30;45(16-18):347-51. Pol Tyg Lek. 1990. PMID: 1700402 Clinical Trial. Polish.
• [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].

  Cianciara J, Loch T, Babiuch L, Dabrowska-Bernstein B, Stasiak A, Dabrowski M, Pawińska A. Cianciara J, et al. Pol Tyg Lek. 1988 Sep 12;43(37):1195-8. Pol Tyg Lek. 1988. PMID: 2470069 Clinical Trial. Polish. No abstract available.
• [Isoprinosine--a drug with antiviral and immunomodulating action].

  Deroń Z. Deroń Z. Wiad Lek. 1984 Sep 1;37(17):1355-61. Wiad Lek. 1984. PMID: 6084363 Review. Polish. No abstract available.
• Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.

  Glasky AJ, Gordon JF. Glasky AJ, et al. Cancer Detect Prev Suppl. 1987;1:597-609. Cancer Detect Prev Suppl. 1987. PMID: 2446760 Review.